| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.82B | 86.97B | 84.72B | 78.76B | 60.30B | 50.93B |
| Gross Profit | 17.75B | 18.37B | 20.82B | 18.32B | 12.30B | 10.06B |
| EBITDA | 7.36B | 8.08B | 10.27B | 9.48B | 6.58B | 5.28B |
| Net Income | 1.97B | 2.19B | 2.45B | 2.32B | 2.37B | 1.93B |
Balance Sheet | ||||||
| Total Assets | 199.53B | 202.04B | 185.02B | 179.12B | 133.89B | 115.65B |
| Cash, Cash Equivalents and Short-Term Investments | 34.67B | 44.63B | 40.46B | 42.33B | 24.98B | 25.22B |
| Total Debt | 19.24B | 18.49B | 25.98B | 15.28B | 22.97B | 21.07B |
| Total Liabilities | 101.79B | 105.40B | 96.96B | 103.60B | 79.12B | 69.50B |
| Stockholders Equity | 34.34B | 34.15B | 31.57B | 28.12B | 26.91B | 22.98B |
Cash Flow | ||||||
| Free Cash Flow | 719.59M | -2.11B | -8.81B | 7.17B | -613.23M | -1.53B |
| Operating Cash Flow | 5.16B | 2.17B | -4.08B | 10.36B | 2.24B | 860.78M |
| Investing Cash Flow | -3.94B | -5.37B | -3.61B | -1.61B | -1.94B | 2.33B |
| Financing Cash Flow | 2.12B | 5.34B | 3.55B | 3.41B | 423.81M | 1.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$15.12B | 12.66 | 13.39% | 3.23% | 2.87% | 17.03% | |
68 Neutral | HK$1.29B | 14.54 | 3.91% | 3.60% | 20.53% | 28.42% | |
66 Neutral | HK$27.11B | 16.56 | 5.05% | 2.28% | 16.93% | -9.02% | |
64 Neutral | HK$54.48B | 8.23 | 11.82% | 4.39% | 1.58% | -16.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | HK$18.71B | 2.09 | 12.27% | 5.84% | 3.17% | 23.13% | |
49 Neutral | HK$2.96B | 4.38 | 7.99% | 6.29% | -7.56% | ― |